Clinical Trial Detail

NCT ID NCT04404569
Title Continued Treatment for Participants Enrolled in Studies of BXQ-350
Recruitment Enrolling by invitation
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bexion Pharmaceuticals, Inc.
Indications

Advanced Solid Tumor

Therapies

BXQ-350

Age Groups: adult child senior

No variant requirements are available.